Get Permission
Rev Diabet Stud, 2005, 2(4):192-207 DOI 10.1900/RDS.2005.2.192

Genes Mediating Environment Interactions in Type 1 Diabetes

Erik Biros, Margaret A. Jordan, Alan G. Baxter

Comparative Genomics Centre, Molecular Sciences Building 21, James Cook University, Townsville QLD 4811, Australia.
Address correspondence to: Alan G. Baxter, e-mail:

Keywords: type 1 diabetes, genes, environment


The relative risk of type 1 (autoimmune) diabetes mellitus for a sibling of an affected patient is fifteen times that of the general population, indicating a strong genetic contribution to the disease. Yet, the incidence of diabetes in most Western communities has doubled every fifteen years since the Second World War - a rate of increase that can only possibly be explained by a major etiological effect of environment. Here, the authors provide a selective review of risk factors identified to date. Recent reports of linkage of type 1 diabetes to genes encoding pathogen pattern recognition molecules, such as toll-like receptors, are discussed, providing a testable hypothesis regarding a mechanism by which genetic and environmental influences on disease progress are integrated.

Fulltext: HTML , PDF (576KB)

This article has been cited by other articles:

Clustering of cases of type 1 diabetes in high socioeconomic communes in Santiago de Chile: spatio-temporal and geographical analysis

Torres-Aviles F, Carrasco E, Icaza G, Perez-Bravo F

Acta Diabetol 2010. 47(3):251-725

Taenia crassiceps infection attenuates multiple low-dose streptozotocin-induced diabetes

Espinoza-Jimenez A, Rivera-Montoya I, Cardenas-Arreola R, Moran L, Terrazas LI

J Biomed Biotechnol 2010. 2010:850541

Functional alterations of proinflammatory monocytes by T regulatory cells: implications for the prevention and reversal of type 1 diabetes

Sia C, Hänninen A

Rev Diabet Stud 2010. 7(1):6-14

Emerging roles for B lymphocytes in Type 1 diabetes

Cox SL, Silveira PA

Expert Rev Clin Immunol 2009. 5(3):311-324

Allelic variation of Ets1 does not contribute to NK and NKT cell deficiencies in type 1 diabetes susceptible NOD mice

Jordan MA, Poulton LD, Fletcher JM, Baxter AG

Rev Diabet Stud 2009. 6(2):104-116

Approaches in type 1 diabetes research: a status report

Raha O, Chowdhury S, Dasgupta S, Raychaudhuri P, Sarkar BN, Raju PV, Rao VR

Int J Diabetes Dev Ctries 2009. 29(2):85-101

Developmental immunotoxicity (DIT) in drug safety testing: matching DIT testing to adverse outcomes and childhood disease risk

Dietert RR

Curr Drug Saf 2008. 3(3):216-226

Genetic Basis of Type 1 Diabetes: Similarities and Differences between East and West

Ikegami H, Noso S, Babaya N, Hiromine Y, Kawabata Y

Rev Diabet Stud 2008. 5(2):64-72

Recent Developments in Patents Targeting Toll-Like Receptor Genes

Saini M, Das DK, Dhara A, Gupta PK

Rec Pat DNA Gene Seq 2007. 1(3):227-239